Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation

Journal of the American College of Cardiology

Volumn 32, Issue 2, 1998, Pages 413-419

  Lamich, Rubén ^a   Ballester, Manel ^a   Martí, Vicens ^a   Brossa, Vicens ^a   Aymat, Rosa ^a   Carrió, Ignasi ^b   Bernà, Lluis ^b   Campreciós, Marta ^a   Puig, Mireia ^a   Estorch, Montserrat ^b   Flotats, Albert ^b   Bordes, Ramón ^b   Garcia, Juan ^a   Augè, Josep M ^a   Padró, Josep M ^a   Caralps, Josep M ^a   Narula, Jagat ^c  

^a Hospital S Creu i S Pau   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; OKT 3; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEART MUSCLE PERFUSION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; VASCULAR DISEASE;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTILYMPHOCYTE SERUM; CAUSE OF DEATH; CHILD; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; EVALUATION STUDIES; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TIME FACTORS; VASCULITIS;

EID: 0032145674     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00234-4     Document Type: Article

References (30)

1. Hosenpud J.D., Shipley G.D., Wagner C.R. Cardiac allograft vasculopathy current concepts, recent developments, and future directions . J Heart Lung Transplant. 11:1992;9.
2. Cooper D.K.C., Novitsky D., Hassaoulas J., Bernard C.N. Heart transplantation the South African Experience . Heart Transplant. 2:1982;78-84.
3. Billingham M.E. Cardiac transplant atherosclerosis. Transplant Proc. 19:1987;19.
4. Gao S.Z., Alderman E.L., Schroeder J.S., et al. Accelerated coronary vascular disease in the heart transplant patient coronary arteriographic findings . J Am Coll Cardiol. 12:1988;334-340.
5. Olivari M.T., Homans D.C., Wilson R.F., et al. Coronary artery disease in cardiac transplant patients receiving triple drug immunosuppressive therapy. Circulation. 80:(suppl III):1989;111-115.
6. Wilson R.F., Christensen B.V., Olivari M.T., Simon A., White C.W., Laxson D.D. Evidence of structural sympathetic reinnervation after orthotopic cardiac transplantation in humans. Circulation. 83:1991;1210-1220.
7. Stark R.P., McGinn A.L., Wilson R.F. Chest pain in cardiac transplant recipients evidence of sensory innervation after cardiac transplantation . N Engl J Med. 324:1991;1791-1794.
8. Schoen F.J., Libby P. Cardiac transplant graft arteriosclerosis. Trends Cardiovasc Med. 1:1991;216.
9. Oni A.A., Ray J., Hosenpud J.D. Coronary venous intimal thickening in explanted cardiac allografts evidence demonstrating that transplant coronary artery disease is a manifestation of a diffuse allograft vasculopathy . Transplantation. 53:1992;1247.
10. Libby P., Schoen F.J., Pober J.S. Arteriosclerosis of cardiac transplantation. Haber E. Molecular Cardiovascular Medicine. 1995;311-324 Scientific American, New York.
11. Häyry P., Mennander A., Raisanen S.A., et al. Pathophysiology of vascular wall changes in chronic allograft rejection. Transplant Rev. 7:1993;1-20.
12. Hammond E.H., Yowell R.L., Nunoda S., et al. Vascular rejection in heart transplantation pathologic observations and clinical implications . J Heart Lung Transplant. 8:1989;430.
13. Hammond E.H., Yowell R.L., Price G.D., et al. Vascular rejection and its relation to allograft coronary artery disease. J Heart Lung Transplant. 11:1992;S111.
14. Abadal A.L., Ballester M., Cladellas M., et al. Vasculitis coronaria aparecida precozmente despues del transplante cardaico diagnostico y tratamiento . Rev Esp Cardiol. 40:1987;74-78.
15. Ballester M., Obrador D., Carrió I., et al. Reversal of rejection-induced coronary vasculitis detected early after heart transplantation with increased immunosuppression. J Heart Lung Transplant. 8:1989;413-417.
16. Johnson D.E., Alderman E.L., Schroeder J.S., et al. Transplant coronary artery disease histologic correlations with angiographic morphology . J Am Coll Cardiol. 17:1991;449-457.
17. Billingham M.E., Cary N.R.B., Hammond M.E., et al. A working formulation for the standardization of the nomenclature in the diagnosis of heart and lung rejection heart rejection study group . J Heart Lung Transplant. 9:1990;587-593.
18. Rodney R.A., Johnson L.L., Blood D.K., Barr M.L. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis a comparison of thallium-201 and technitium-99m Sestamibi . J Heart Lung Transplant. 13:1994;173-180.
19. Smart F.W., Ballantyne C.M., Cocanougher B., et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplantation. Am J Cardiol. 67:1991;243-247.
20. McKillop J.H., Gorris M.L. Thallium-201 myocardial imaging in patients with previous cardiac transplantation. Clin Radiol. 32:1981;447-449.
21. Howarth M., Forstrom A., Samudrala V., Sinak J., McGregor G., Rodeheffer J. Evaluation of Tl-201 SPET myocardial perfusion imaging in the detection of coronary artery disease after orthotopic heart transplantation. Nucl Med Commun. 17:1996;105-113.
22. Ciliberto G.R., Mangiavacchi M., Banfi F., et al. Coronary artery disease after heart transplantation. Eur Heart J. 14:1993;226-229.
23. Rodney R.A., Johnson L.L. Myocardial perfusion scintigraphy to assess heart transplantation vasculopathy. J Heart Lung Transplant. 11:1992;S74-S78.
24. Hutchinson I.V. Effector mechanisms in transplant rejection - an overview. Rose M.L., Yacoub M.H. Immunology of Heart and Lung Transplantation. 1993;10 Edward-Arnold, London.
25. English T.A.H., McGregor C., Wallwork J., Cory-Pearce R. Aspects of immunosuppression for cardiac transplantation. Heart Transplant. 4:1982;280-284.
26. Jamieson S.W., Stinson E.B. Cardiac transplantation for end-stage ischemic heart disease. Connor W.E., Bristow J.P. Coronary Heart Disease. 1985;487-494 JB Lippincott, Philadelphia.
27. Greenberg M.L., Uretsky B.F., Reddy S., et al. Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone. Circulation. 71:1985;487-494.
28. Olsen S.L., Wagner L.E., Hammond E.H., et al. Vascular rejection in heart transplantation clinical correlation, treatment options, and future considerations . J Heart Lung Transplant. 12:1993;S135-S142.
29. St. Goar F.G., Pinto F.J., Alderman E.L., et al. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening. Circulation. 85:1992;979-987.
30. St. Goar F.G., Pinto F.J., Alderman E.L., Fitzgerald P.J., Stadius M.L., Popp R.L. Intravascular ultrasound imaging of angiographically normal coronary arteries an in vivo comparison with quantitative angiography . J Am Coll Cardiol. 18:1991;952-958.